Seeking men and women with mild to moderate COVID-19 infection who have tested positive within the last 3 days for a study of an investigational drug that has been approved for use in other countries for the flu and other viral illnesses.
Participants in this study will be randomly assigned to get either the investigational drug or a placebo (looks like the drug but contains no medicine).
What we're hoping for
We are studying whether a drug that has been approved for use in other countries for the flu and other viral illnesses is safe and effective in reducing the severity of COVID-19 in adults with mild to moderate symptoms.
ClinicalTrials.gov Identifier: NCT04600895